Targeted exonic sequencing of GWAS loci in the high extremes of the plasma lipids distribution

Atherosclerosis

Volumn 250, Issue , 2016, Pages 63-68

  Patel, Aniruddh P ^a,b   Peloso, Gina M ^a,b   Pirruccello, James P ^a,b   Johansen, Christopher T ^c   Dubé, Joseph B ^c   Larach, Daniel B ^d   Ban, Matthew R ^c   Dallinge Thie, Geesje M ^e   Gupta, Namrata ^b   Boehnke, Michael ^f   Abecasis, Gonçalo R ^f   Kastelein, John J P ^e   Hovingh, G Kees ^e   Hegele, Robert A ^c   Rader, Daniel J ^g   Kathiresan, Sekar ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF MICHIGAN   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Genetic techniques; Genomics; Human genetics; Lipids

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CODING; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE LOCUS; GENE SEQUENCE; GENOME-WIDE ASSOCIATION STUDY; HUMAN; LIPID BLOOD LEVEL; MALE; MISSENSE MUTATION; NEXT GENERATION SEQUENCING; NONSENSE MUTATION; PRIORITY JOURNAL; AGED; BLOOD; CHROMOSOMAL MAPPING; COHORT ANALYSIS; DNA SEQUENCE; GENETIC VARIATION; GENETICS; MIDDLE AGED; PHENOTYPE; QUALITY CONTROL;

ADULT; AGED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHROMOSOME MAPPING; COHORT STUDIES; EXONS; FEMALE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PHENOTYPE; QUALITY CONTROL; SEQUENCE ANALYSIS, DNA; TRIGLYCERIDES;

EID: 84966707967     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.04.011     Document Type: Article

References (46)

1. Kannel W.B., Dawber T.R., Kagan A., Revotskie N., Stokes J. Factors of risk in the development of coronary heart disease-six year follow-up experience. The framingham study. Ann. Intern. Med. 1961, 55:33-50.
2. Kathiresan S., Melander O., Guiducci C., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 2008, 40:189-197.
3. Kathiresan S., Willer C.J., Peloso G.M., et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 2009, 41:56-65.
4. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., De Bakker P.I.W., Chen H., Roix J.J., Kathiresan S., Hirschhorn J.N., Daly M.J., Hughes T.E., Groop L., Altshuler D. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
5. Teslovich T.M., Musunuru K., Smith A.V., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
6. Willer C.J., Sanna S., Jackson A.U., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 2008, 40:161-169.
7. Aulchenko Y.S., Ripatti S., Lindqvist I., et al. Loci influencing lipid levels and coronary heart disease risk in 16 european population cohorts. Nat. Genet. 2009, 41:47-55.
8. Sabatti C., Service S.K., Hartikainen A.L., et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat. Genet. 2009, 41:35-46.
9. Willer C.J., Schmidt E.M., et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 2013, 45:1274-1283. C Global Lipids Genetics.
10. Nejentsev S., Walker N., Riches D., Egholm M., Todd J.A. Rare variants of ifih1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
11. Galarneau G., Palmer C.D., Sankaran V.G., Orkin S.H., Hirschhorn J.N., Lettre G. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat. Genet. 2010, 42:1049-1051.
12. Raychaudhuri S., Iartchouk O., Chin K., et al. A rare penetrant mutation in cfh confers high risk of age-related macular degeneration. Nat. Genet. 2011, 43:1232-1236.
13. Helgason H., Sulem P., Duvvari M.R., et al. A rare nonsynonymous sequence variant in c3 is associated with high risk of age-related macular degeneration. Nat. Genet. 2013, 45:1371-1376.
14. Seddon J.M., Yu Y., Miller E.C., et al. Rare variants in cfi, c3 and c9 are associated with high risk of advanced age-related macular degeneration. Nat. Genet. 2013, 45:1366-1373.
15. Van De Ven J.P.H., Nilsson S.C., Tan P.L., et al. A functional variant in the cfi gene confers a high risk of age-related macular degeneration. Nat. Genet. 2013, 45:813-817.
16. Zhan X., Larson D.E., Wang C., et al. Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat. Genet. 2013, 45:1375-1381.
17. Rivas M.A., Beaudoin M., Gardet A., et al. Deep resequencing of gwas loci identifies independent rare variants associated with inflammatory bowel disease. Nat. Genet. 2011, 43:1066-1073.
18. Gnirke A., Melnikov A., Maguire J., Rogov P., LeProust E.M., Brockman W., Fennell T., Giannoukos G., Fisher S., Russ C., Gabriel S., Jaffe D.B., Lander E.S., Nusbaum C. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat. Biotechnol. 2009, 27:182-189.
19. Depristo M.A., Banks E., Poplin R., et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 2011, 43:491-501.
20. Cingolani P., Platts A., Wang le L., Coon M., Nguyen T., Wang L., Land S.J., Lu X., Ruden D.M. A program for annotating and predicting the effects of single nucleotide polymorphisms, snpeff: snps in the genome of drosophila melanogaster strain w1118; iso-2; iso-3. Fly 2012, 6:80-92.
21. Price A.L., Kryukov G.V., de Bakker P.I.W., Purcell S.M., Staples J., Wei L.J., Sunyaev S.R. Pooled association tests for rare variants in exon-resequencing studies. Am. J. Hum. Genet. 2010, 86:832-838.
22. Neale B.M., Rivas M.A., Voight B.F., Altshuler D., Devlin B., Orho-Melander M., Kathiresan S., Purcell S.M., Roeder K., Daly M.J. Testing for an unusual distribution of rare variants. PLoS Genet. 2011, 7:e1001322.
23. McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., Garimella K., Altshuler D., Gabriel S., Daly M., DePristo M.A. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010, 20:1297-1303.
24. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., Maller J., Sklar P., De Bakker P.I.W., Daly M.J., Sham P.C. Plink: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
25. Plink/seq: A Library for the Analysis of Genetic Variation Data 2012.
26. RDC Team R: A Language and Environment for Statistical Computing 2010.
27. McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D.R., Hinds D.A., Pennacchio L.A., Tybjaerg-Hansen A., Folsom A.R., Boerwinkle E., Hobbs H.H., Cohen J.C. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
28. Clarke R., Peden J.F., Hopewell J.C., et al. Genetic variants associated with lp(a) lipoprotein level and coronary disease. N. Engl. J. Med. 2009, 361:2518-2528.
29. Kathiresan S., Voight B.F., Purcell S., et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 2009, 41:334-341.
30. Tobin M.D., Sheehan N.A., Scurrah K.J., Burton P.R. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Statistics Med. 2005, 24:2911-2935.
31. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., Kirby A., Sourjina T., Peto R., Collins R., Simes R. C cholesterol treatment trialists. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.
32. Crosby J., Peloso G.M., Auer P.L., et al. Loss-of-function mutations in apoc3, triglycerides, and coronary disease. N. Engl. J. Med. 2014, 371:22-31.
33. Kondo I., Berg K., Drayna D., Lawn R. DNA polymorphism at the locus for human cholesteryl ester transfer protein (cetp) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin. Genet. 1989, 35:49-56.
34. Patsch J.R., Prasad S., Gotto A.M., Patsch W. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J. Clin. Investig. 1987, 80:341-347.
35. Farrelly D., Brown K.S., Tieman A., Ren J., Lira S.A., Hagan D., Gregg R., Mookhtiar K.A., Hariharan N. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14511-14516.
36. Soria L.F., Ludwig E.H., Clarke H.R.G., Vega G.L., Grundy S.M., McCarthy B.J. Association between a specific apolipoprotein b mutation and familial defective apolipoprotein b-100. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:587-591.
37. Pennacchio L.A., Olivier M., Hubacek J.A., Cohen J.C., Cox D.R., Fruchart J.C., Krauss R.M., Rubin E.M. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294:169-173.
38. Green P.H.R., Glickman R.M., Riley J.W., Quinet E. Human apolipoprotein a-iv. Intestinal origin and distribution in plasma. J. Clin. Investig. 1980, 65:911-919.
39. Green P.H.R., Glickman R.M., Saudek C.D., Blum C.B., Tall A.R. Human intestinal lipoproteins. Studies in chyluric subjects. J. Clin. Investig. 1979, 64:233-242.
40. Karathanasis S.K. Apolipoprotein multigene family: tandem organization of human apolipoprotein ai, ciii, and aiv genes. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:6374-6378.
41. Karathanasis S.K., Oettgen P., Haddad I.A., Antonarakis S.E. Structure, evolution, and polymorphisms of the human apolipoprotein a4 gene (apoa4). Proc. Natl. Acad. Sci. U. S. A. 1986, 83:8457-8461.
42. Steinmetz A., Utermann G. Activation of lecithin:cholesterol acyltransferase by human apolipoprotein a-iv. J. Biol. Chem. 1985, 260:2258-2264.
43. Dunham I., Kundaje A., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. EP Consortium.
44. Hunt K.A., Mistry V., Bockett N.A., et al. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 2013, 498:232-235.
45. Peloso G.M., Rader D.J., Gabriel S., Kathiresan S., Daly M.J., Neale B.M. Phenotypic extremes in rare variant study designs. Eur. J. Hum. Genet. 2015.
46. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.